Valuation Traphaco

Stocks

End-of-day quote Ho Chi Minh S.E. 30/09/2026			5-day change	1st Jan Change
37,000.00 ^VND	+0.54%		-5.01%	-1.33%

09-14	Traphaco Joint Stock Company Announces Change in Enterprise Registration Certificate	CI
09-03	Traphaco Joint Stock Company Announces Appointment of Nguyen Phu Khanh as Deputy General Director for Finance and Planning, Effective August 25, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	2,967,859	3,780,289	3,689,098	3,689,098	3,253,867	3,108,790
Change	-	27.37%	-2.41%	0%	-11.8%	-4.46%
Enterprise Value (EV) ¹	2,627,509	3,309,117	3,227,397	3,074,674	2,713,414	2,539,407
Change	-	25.94%	-2.47%	-4.73%	-11.75%	-6.41%
P/E	17.1x	17.6x	15.6x	16.1x	15.7x	14.3x
PBR	2.75x	3.24x	2.89x	2.67x	2.29x	2x
PEG	-	0.7x	1.57x	-5.88x	-1.59x	2.97x
Capitalization / Revenue	1.55x	1.75x	1.54x	1.6x	1.39x	1.17x
EV / Revenue	1.38x	1.53x	1.35x	1.34x	1.16x	0.96x
EV / EBITDA	7.52x	8.09x	7.43x	7.25x	6.89x	6.16x
EV / EBIT	9.77x	10.1x	9.21x	9.22x	8.85x	7.84x
EV / FCF	9.66x	12.6x	32x	12.4x	47x	42.2x
FCF Yield	10.4%	7.92%	3.12%	8.06%	2.13%	2.37%
Dividend per Share ²	1,500	1,500	1,500	2,000	2,000	-
Rate of return	4.19%	3.29%	3.37%	4.49%	5.1%	-
EPS ²	2,092	2,588	2,845	2,768	2,495	2,615
Distribution rate	71.7%	57.9%	52.7%	72.3%	80.2%	-
Net sales ¹	1,908,870	2,160,840	2,398,918	2,299,235	2,347,221	2,657,210
EBITDA ¹	349,535	408,895	434,258	424,189	394,063	412,206
EBIT ¹	269,072	326,581	350,578	333,373	306,455	323,920
Net income ¹	195,787	241,591	269,145	263,248	239,017	249,655
Net Debt ¹	-340,350	-471,173	-461,701	-614,424	-540,453	-569,384
Reference price ²	35,800.00	45,600.00	44,500.00	44,500.00	39,250.00	37,500.00
Nbr of stocks (in thousands)	82,901	82,901	82,901	82,901	82,901	82,901
Announcement Date	8/3/21	11/3/22	29/3/23	21/3/24	28/3/25	26/3/26

¹VND in Million²VND

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TRAPHACO	-	-	-	-	118M
ELI LILLY AND COMPANY	32.9x	11.93x	24.23x	0.6%	1,031B
JOHNSON & JOHNSON	29.45x	6.54x	18.31x	2.02%	638B
ABBVIE INC.	33.1x	7.75x	16.02x	2.65%	462B
MERCK & CO., INC.	105.72x	5.91x	25.05x	2.35%	359B
ROCHE HOLDING AG	19x	4.63x	11.48x	2.87%	335B
NOVARTIS AG	20.37x	5.28x	13.08x	3.03%	273B
ASTRAZENECA PLC	20.79x	4.31x	12.28x	2.05%	253B
AMGEN INC.	26.62x	6.92x	12.32x	2.39%	228B
GILEAD SCIENCES, INC.	-45.08x	6.57x	25.65x	2.21%	185B
Average	26.98x	6.65x	17.60x	2.24%	376.4B
Weighted average by Cap.	32.10x	7.72x	18.90x	1.92%